U.S. Markets open in 6 hrs, 14 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,309.92 | -154.48 | -1.48% |
| NASDAQ | 2,138.44 | -37.61 | -1.73% |
| S&P 500 | 1,091.49 | -19.14 | -1.72% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 36.83 09:40 AM EST | |
|---|---|---|
| Day High | 37.33 09:32 AM EST |
|
| Range | 0.50 |
| Volume | 474,765 | |
|---|---|---|
| 30-Day Avg Vol | 1.17 M |
|
| Difference | -59.42% |
| Market Cap | 3.92 B | |
|---|---|---|
| Mkt Cap Chg | -90.21 M |
| Shares Out | 106.14 M | |
|---|---|---|
| % Shrs Traded | 0.45% | |
| 1yr EPS Est | 2.632 |
| 52-Wk Low | 21.77 | |
|---|---|---|
| 52-Wk High | 38.48 |
|
| Range | 16.71 |
| Prev Close | 37.81 11/25/09 | |
|---|---|---|
| Today's Open | 37.28 | |
| Change | -1.40% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.65 M |
| Revenue (LFY) | 2.53 B | |
|---|---|---|
| Earnings (LFY) | 238.38 M | |
| Earnings (MRQ) | 63.00 M | |
| Next Earn Est | 0.722 | |
| Next Earnings | 02/17/2010 |
|
| EPS (TTM) | 1.95 | |
| 1yr EPS Growth | 10.59% |
| P/E Ratio (TTM) | 19.05 | |
|---|---|---|
| P/E Ratio (Fwd) | 14.00 | |
| PEG Ratio | 1.16 | |
| Return on Equity | 10.35 | |
| Beta | 0.59 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Watson Pharmaceuticals tries to have the best of both worlds, with operations in the US generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.722 2/17/10 | — — |
—
—
|
| Last Quarter | 0.65 9/30/09 | 0.66 9/30/09 |
0.01
Beat
|
| 2 Quarters Ago | 0.572 6/30/09 | 0.61 6/30/09 |
0.038
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 662.10 M | 2.54 B |
| Gross Profit | 286.20 M | 980.04 M |
| Operating Income | 114.20 M | 388.88 M |
| Net Income | 63.00 M | 238.38 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts